Pharmacy

Jetdoc And Rick Ross Announce Strategic Partnership

Monday, November 30, 2020 - 3:30pm

ATLANTA, Nov. 30, 2020 /PRNewswire/ --Jetdoc, a revolutionary digital healthcare platform that connects you with a licensed healthcare professional in minutes, today announced a strategic partnership with hip-hop superstar and entrepreneur William Leonard Roberts II, known professionally as Rick Ross, to sign on as a spokesperson, investor and advisor.

Key Points: 
  • ATLANTA, Nov. 30, 2020 /PRNewswire/ --Jetdoc, a revolutionary digital healthcare platform that connects you with a licensed healthcare professional in minutes, today announced a strategic partnership with hip-hop superstar and entrepreneur William Leonard Roberts II, known professionally as Rick Ross, to sign on as a spokesperson, investor and advisor.
  • In his new role with Jetdoc, Rick Ross will appear in creative campaigns, digital and television ads and other promotional activations designed to educate and inform consumers of this innovative new offering in healthcare.
  • In addition to safe and affordable care, Jetdoc members will also receive a free Jetdoc DiscountRx Card for up to 85% off retail prices for prescription medication at most major retailer pharmacies.
  • Jetdoc puts the power of managing our health into our own hands," said Rick Ross.

Annexus Health shines a light on patient financial toxicity with new initiative

Monday, November 30, 2020 - 2:30pm

WILMINGTON, Del., Nov. 30, 2020 /PRNewswire/ --Annexus Health recently launched an initiative aimed at increasing awareness of patient financial toxicitythe hardships resulting from expensive and frequently unaffordable health care.

Key Points: 
  • WILMINGTON, Del., Nov. 30, 2020 /PRNewswire/ --Annexus Health recently launched an initiative aimed at increasing awareness of patient financial toxicitythe hardships resulting from expensive and frequently unaffordable health care.
  • In a series of video vignettes featured on the Annexus website , three cancer survivors share their personal experiences with financial toxicity:
    "Cancer takes its own toll on you.
  • When you bring in the financial impact of it, it's really devastating to your soul."
  • Annexus Health is a privately-held, healthcare technology company, focused on developing solutions that reduce administrative burdens across the patient journey to improve access, speed, and adherence to critical care.

Elevar Therapeutics Appoints Gus Aromin as Vice President of Regulatory Affairs

Monday, November 30, 2020 - 2:00pm

SALT LAKE CITY, Nov. 30, 2020 /PRNewswire/ --Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, announced today that Gus Aromin has been named vice president of regulatory affairs, effective immediately.

Key Points: 
  • SALT LAKE CITY, Nov. 30, 2020 /PRNewswire/ --Elevar Therapeutics, Inc. ("Elevar"), a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options, announced today that Gus Aromin has been named vice president of regulatory affairs, effective immediately.
  • "This has been a pivotal year for Elevar as we have expanded our medical affairs function, announced important updates in our pipeline, executed strategic partnerships, and are now building out a robust global regulatory affairs infrastructure.
  • "I'm excited to join Elevar to help build the regulatory affairs infrastructure and execute their development programs and pre-commercial strategy," said Gus Aromin, vice president of regulatory affairs at Elevar.
  • Elevar Therapeutics has offices in Utah, California and South Korea, and additional information is available at www.elevartherapeutics.com .

Tabula Rasa HealthCare Names Celynda G.Tadlock, PharmD, MBA, Chief Client Officer and EVP of Pharmacy Benefit Services

Monday, November 30, 2020 - 1:00pm

MOORESTOWN, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of Celynda G.Tadlock, PharmD, MBA as the Companys Chief Client Officer and EVP of Pharmacy Benefit Services.

Key Points: 
  • MOORESTOWN, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced the appointment of Celynda G.Tadlock, PharmD, MBA as the Companys Chief Client Officer and EVP of Pharmacy Benefit Services.
  • Dr. Tadlocks goal will be to create a persistent focus on the client to support needed action to assure client and Company success.
  • Her expertise in pharmacy benefit management (PBM) and services will transition recent acquisitions quickly and efficiently into a combined organization that leverages TRHCs proprietary science and services.
  • She frequently is asked to speak at national stage forums relative to managed care, specialty pharmacy and pharmacy benefit management.

Scout Bio to Present at the Guggenheim Healthcare Talks Animal Health Veterinary Summit

Monday, November 30, 2020 - 1:00pm

PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Scout Bio,a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions, today announced that Mark Heffernan, Scout Bios Chief Executive Officer, will present on the Blockbusters of 2024 panel at the upcoming Guggenheim Healthcare Talks Animal Health Veterinary Summit at 1:20 p.m.

Key Points: 
  • PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Scout Bio,a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions, today announced that Mark Heffernan, Scout Bios Chief Executive Officer, will present on the Blockbusters of 2024 panel at the upcoming Guggenheim Healthcare Talks Animal Health Veterinary Summit at 1:20 p.m.
  • Scout Bio is a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions.
  • Scouts therapeutics are designed to induce long-term expression of therapeutic proteins in pet patients using AAV vector technology.
  • Scout Bio is a private company headquartered in Philadelphia, PA. For more information, please visit www.scoutbio.co .

Intra-Cellular Therapies to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Monday, November 30, 2020 - 1:00pm

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com.

Key Points: 
  • The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com.
  • Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
  • Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body.
  • The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

1,200 Independent Pharmacies to Offer At-Home COVID-19 Test

Monday, November 30, 2020 - 1:00pm

Patients at more than 1,200 independent pharmacies across the country now have access to a saliva-based, at-home COVID-19 test.

Key Points: 
  • Patients at more than 1,200 independent pharmacies across the country now have access to a saliva-based, at-home COVID-19 test.
  • View the full release here: https://www.businesswire.com/news/home/20201130005015/en/
    More than 1,200 independent pharmacies served by Pharmacy Providers of Oklahoma can now offer their patients a saliva-based, at-home COVID-19 test.
  • Making this test available allows independent pharmacies to compete with the big box stores and increases consumer access.
  • Wheeler Labs COVID-19 test kits can also be ordered online at www.wheeler-labs.com and shipped directly to homes, businesses, pharmacies and clinics.

Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing

Monday, November 30, 2020 - 8:00am

OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and gene therapy plasmid DNA (pDNA), announces a new agreement with Nature Technology Corporation (NTC) for use of NTCs proprietary HyperGRO manufacturing platform.

Key Points: 
  • OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and gene therapy plasmid DNA (pDNA), announces a new agreement with Nature Technology Corporation (NTC) for use of NTCs proprietary HyperGRO manufacturing platform.
  • This announcement is on the heels of Cytovance launching its Keystone Expression System pDNA manufacturing licensing program.
  • Our pDNA programs have greatly advanced due, in-part, to our use of NTCs HyperGRO technology, stated Bin Zhang, CEO of Cytovance Biologics.
  • Cytovance is highly experienced in pDNA manufacturing and offers three quality levels including R&D Grade, Cytograde and CGMP Grade depending on the needs of the client.

Pharmaceutical Formulation Market Procurement Report | Roadmap to Recovery for Businesses from the Impact of COVID-19 Pandemic | SpendEdge

Sunday, November 29, 2020 - 5:30am

The new Pharmaceutical Formulation market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.

Key Points: 
  • The new Pharmaceutical Formulation market research report from SpendEdge indicates an incremental growth during the forecast period as the business impact of COVID-19 spreads.
  • View the full release here: https://www.businesswire.com/news/home/20201128005042/en/
    SpendEdge has announced the release of its Global Pharmaceutical Formulation Market Procurement Intelligence Report (Graphic: Business Wire)
    As the markets recover SpendEdge expects the Pharmaceutical Formulation market size to grow by USD 183 billion during the period 2020-2024.
  • Get detailed insights on the COVID-19 pandemic crisis and recovery analysis of the Pharmaceutical Formulation market.
  • Download free report sample
    Analysis of the cost and volume drivers and supply market forecasts in various regions are offered in this Pharmaceutical Formulation research report.

Laboratory Centrifuge Market: Impact and Recovery Report | Evolving Opportunities and New Market Possibilities Post Pandemic | SpendEdge

Friday, November 27, 2020 - 9:30pm

SpendEdge suggests various forecast scenarios considering the impact of COVID-19.

Key Points: 
  • SpendEdge suggests various forecast scenarios considering the impact of COVID-19.
  • SpendEdges in-depth research has direct and indirect COVID-19 impacted market research reports.
  • SpendEdge's SUBSCRIPTION platform
    Related Reports on Pharma and Healthcare Include:
    Pharmaceutical Drug Development Services - Sourcing and Procurement Intelligence Report : The pharmaceutical drug development services will grow at a CAGR of 9.34% during 2020-2024.
  • Prices in will increase by 3%-6% during the forecast period and suppliers will have a moderate bargaining power in this market.